E. Scelzi

491 total citations
11 papers, 311 citations indexed

About

E. Scelzi is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, E. Scelzi has authored 11 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in E. Scelzi's work include Glioma Diagnosis and Treatment (4 papers), Erythropoietin and Anemia Treatment (2 papers) and Brain Metastases and Treatment (2 papers). E. Scelzi is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Erythropoietin and Anemia Treatment (2 papers) and Brain Metastases and Treatment (2 papers). E. Scelzi collaborates with scholars based in Italy and Japan. E. Scelzi's co-authors include Alba A. Brandes, Franco Berti, Mario V. Fiorentino, Paolo Zampieri, Mario Ermani, C. Carollo, G Salmistraro, Pietro Amistà, Antonino Rotilio and S. Turazzi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

E. Scelzi

10 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Scelzi Italy	6	156	117	86	75	59	11	311
Chika Shigemori Japan	5	56 0.4×	84 0.7×	10 0.1×	37 0.5×	6 0.1×	8	359
Hyehyun Jeong South Korea	10	18 0.1×	14 0.1×	34 0.4×	90 1.2×	50 0.8×	46	272
Peter Meeus Belgium	11	169 1.1×	24 0.2×	19 0.2×	12 0.2×	8 0.1×	20	385
Jonathan Lambert United Kingdom	9	115 0.7×	19 0.2×	11 0.1×	24 0.3×	31 0.5×	25	235
François Leroy-Ladurie France	10	33 0.2×	12 0.1×	40 0.5×	357 4.8×	29 0.5×	14	508
Jackline de Paula Ayres-Silva Brazil	7	145 0.9×	14 0.1×	15 0.2×	11 0.1×	124 2.1×	13	291
Laurent Taillade France	9	14 0.1×	11 0.1×	24 0.3×	111 1.5×	10 0.2×	13	286
Lamia Lamrani France	5	58 0.4×	29 0.2×	25 0.3×	30 0.4×	3 0.1×	9	231
Jiedan Ping China	10	6 0.0×	66 0.6×	31 0.4×	28 0.4×	10 0.2×	12	287
Mathias Hoiczyk Germany	10	17 0.1×	16 0.1×	12 0.1×	218 2.9×	41 0.7×	20	386

Countries citing papers authored by E. Scelzi

Since Specialization

Citations

This map shows the geographic impact of E. Scelzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Scelzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Scelzi more than expected).

Fields of papers citing papers by E. Scelzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Scelzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Scelzi. The network helps show where E. Scelzi may publish in the future.

Co-authorship network of co-authors of E. Scelzi

This figure shows the co-authorship network connecting the top 25 collaborators of E. Scelzi. A scholar is included among the top collaborators of E. Scelzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Scelzi. E. Scelzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Rosti, Giovanni, Mario Petrini, Alberto Bosi, et al.. (2016). Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study. Therapeutic Advances in Medical Oncology. 9(1). 22–32. 9 indexed citations

Scelzi, E., Daniela Bernardi, Giorgio Bonciarelli, et al.. (2015). Biosimilar epoetin alfa in the management of chemotherapy-induced aneamia: results from ANEMONE observational study. Annals of Oncology. 26. vi121–vi121. 1 indexed citations

Vicario, Giovanni, et al.. (2010). Pegylated liposomal doxorubicin for adjuvant treatment of breast cancer in patients refusing therapy with conventional doxorubicin.. Journal of Clinical Oncology. 28(15_suppl). e11097–e11097. 1 indexed citations

Vicario, Giovanni, Maria Teresa Bortolin, E. Scelzi, et al.. (2008). Does PET/CT modify the therapeutic approach in medical oncology?. Journal of Clinical Oncology. 26(15_suppl). 17525–17525. 1 indexed citations

Ridolfi, Ruggero, E. Scelzi, S. Palmeri, et al.. (2003). Chemotherapy and Bio-Chemotherapy in Patients with Advanced Melanoma: Combination Therapy with a Nitrosourea. Journal of Chemotherapy. 15(2). 198–202. 2 indexed citations

Brandes, Alba A., Mario Ermani, S. Turazzi, et al.. (1999). Procarbazine and High-Dose Tamoxifen as a Second-Line Regimen in Recurrent High-Grade Gliomas: A Phase II Study. Journal of Clinical Oncology. 17(2). 645–645. 70 indexed citations

Brandes, Alba A., C. Carollo, Marina Paola Gardiman, et al.. (1998). Unusual nasal and orbital involvement of glioblastoma multiforme: A case report and review of the literature. Journal of Neuro-Oncology. 36(2). 179–183. 8 indexed citations

Brandes, Alba A., E. Scelzi, G Salmistraro, et al.. (1997). Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study. European Journal of Cancer. 33(10). 1592–1596. 164 indexed citations

Brandes, Alba A., E. Scelzi, Paolo Zampieri, et al.. (1997). Phase II Trial with BCNU plus α-Interferon in Patients with Recurrent High-Grade Gliomas. American Journal of Clinical Oncology. 20(4). 364–367. 32 indexed citations

10.

Brandes, Alba A., Alberto Rigon, Paolo Zampieri, et al.. (1996). Early chemotherapy and concurrent radio-chemotherapy in high grade glioma. Journal of Neuro-Oncology. 30(3). 247–55. 21 indexed citations

11.

Scelzi, E., et al.. (1994). Tamoxifen (JAM) and interferon alfa 2a (IFN) in metastatic melanoma. Melanoma Research. 4(2). 51–51. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact